Skip to content

To evaluate the efficacy of Lodhra Arka Aschyotana in the management of Kaphaja Abhishyanda.

A randomized open-label controlled clinical study to evaluate the efficacy of Lodhra Arka Aschyotana in the management of Kaphaja Abhishyanda. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068459
Enrollment
30
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H109- Unspecified conjunctivitis

Interventions

None listed

Sponsors

Dr Sharon K Manohar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 21-40 years irrespective of gender, occupation, religion and socio-economic status. 2.Subjects fulfilling the diagnostic criteria. 3.Subjects willing to undergo trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.History of any intraocular surgery. 2.Subject having any ocular trauma 3.Diagnosed cases of glaucoma. 4.Subjects having any uncontrolled systemic illness that can interfere with the course of disease and treatment. 5.Subjects suffering from an infective disease of the eye like Uveitis, Scleritis, Keratitis, Stye, Endophthalmitis, Blepharitis,Retinitis, Dacryocystitis. 6.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Significant improvement in the signs and symptoms of Kaphaja Abhishyanda. Timepoint: Pre assessment-0th day Post assessment-8 th day 1st follow up-15th day 2nd follow up-30th day

Secondary

MeasureTime frame
1.Generation of in depth analysed data on the different aspect of the disease. 2.Generation of data on possible drug reaction. Timepoint: Pre assessment-0th day Post assessment-8 th day 1st follow up-15th day 2nd follow up-30th day

Countries

India

Contacts

Public ContactDr Naveen B S

Sri Sri College of Ayurvedic Science and Research

navs009@gmail.com09497659608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026